查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1555480

脑疾病模式和软体市场，按产品类型、患者类型、适应症、最终用户、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Brain Disease Modalities and Software Market, By Product Type, By Patient Type, By Indication, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 269 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告要点

2023 年脑部疾病模式和软体市场规模为 136.9032 亿美元，2024 年至 2032 年复合年增长率为 5.90%。

脑疾病模式与软体市场-市场动态

神经系统疾病的日益普及以及对更安全和非侵入性影像设备的需求预计将推动市场的成长

随着全球人口老化，神经系统疾病的盛行率显着上升，包括阿兹海默症、帕金森氏症、多发性硬化症和癫痫。患者人口的不断扩大需要开发复杂的诊断和治疗方法。 2021 年，神经系统疾病导致因疾病、残疾和过早死亡（以残疾调整生命年衡量）而损失的 4.43 亿年健康寿命，使其成为全球疾病负担的主要原因，超过心血管疾病，由健康指标与评估研究所报告。 MRI 和 PET 扫描等非侵入性影像技术为侵入性方法提供了更安全的替代方案，最大限度地降低了患者出现併发症和不适的风险，从而促进了其更广泛的接受。此外，影像技术的进步，包括高解析度 MRI、功能性 MRI (fMRI) 和增强型 PET 扫描，为脑部疾病模式和软体市场创造了机会。然而，有限的意识和可及性可能会对市场的成长构成挑战。

脑疾病模式和软体市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 5.90% 左右的复合年增长率成长

根据产品类型细分，预计脑部影像模式将在 2023 年显示最大的市场份额

根据患者类型细分，儿科是 2023 年的主导类型

根据适应症细分，创伤性脑损伤（TBI）是2023年的主导类型

根据最终用户细分，诊断影像中心是 2023 年的主导类型

按地区划分，北美是 2023 年的主要收入来源

脑疾病模式与软体市场細項分析：

全球脑疾病模式和软体市场根据产品类型、患者类型、适应症、最终用户和地区进行细分。

根据产品类型，市场分为两类：脑部分析软体和脑部影像模式。脑成像模式占据市场的大部分份额。在这个领域中，大脑成像模式对于全面了解大脑结构和功能至关重要。

根据患者类型，市场分为三组：成人、婴儿和儿科。儿科占据最大的市场份额。专业的影像模式和软体解决方案对于儿科神经病学中有效诊断和治疗年轻患者的脑部疾病至关重要。

根据适应症，市场分为八类：创伤性脑损伤（TBI）、头痛疾病、癫痫、睡眠障碍、巴金森氏症、中风、亨丁顿舞蹈症和失智症。创伤性脑损伤（TBI）在市场上占有最大份额。 TBI 是一个重要的重点领域，利用尖端的脑部影像技术和软体解决方案来增强诊断、监测和復健。

根据最终用户，市场分为三个不同的类别：医院和诊所、门诊手术中心和诊断影像中心。其中，诊断影像中心占市场主导地位。这些设施采用各种脑部影像技术和软体应用程式来诊断、监测和管理神经系统疾病。

脑疾病模式与软体市场 - 地理洞察

市场地域广阔，涵盖北美、拉丁美洲、欧洲、亚太地区、中东和非洲。这些领域根据对商业活动做出贡献的国家进一步分类。北美是领先地区，这主要是由于人工智慧在医学影像中的日益融合以及显着的技术进步。具体来说，美国和加拿大处于将人工智慧和机器学习纳入医学影像和诊断软体的前沿。这些创新有助于增强影像分析、提高诊断精度并优化工作流程，从而为北美公司提供竞争优势。 2020 年，美国放射学会 (ACR) 接受了一项调查，评估其成员在临床环境中人工智慧的使用情况，收到 1,427 份回复，结果显示 33.5% 的放射科医生在其实践中使用人工智慧。由于医疗保健支出和采用率较高，欧洲成为市场成长的第二大地区。

脑疾病模式与软体市场-竞争格局：

脑疾病模式和软体市场竞争激烈，许多参与者都在努力透过创新、策略联盟和技术进步来确保市场份额。公司正在研发方面进行大量投资，以创建最先进的成像模式和软体解决方案。重点强调人工智慧和机器学习，这对于提高诊断精度和营运效率至关重要。领先公司正在收购小型企业和新创公司，以扩大其技术能力并获得脑部疾病诊断和治疗的创新成果。此外，组织正在透过渗透新的地理区域和新兴市场来增强其市场影响力，从而利用对复杂脑部疾病诊断工具不断增长的需求。

最新进展：

2022 年5 月6 日，在国际医学磁振造影学会(ISMRM) 2022 年年会上，GE 医疗宣布透过升级和升级，进一步向其广泛的客户群推出其创新的深度学习影像重建解决方案AIR Recon DL 。

全球领先的健康技术实体皇家飞利浦与位于瑞典林雪平的专门从事磁振造影 (MRI) 软体解决方案的 Synthetic MR 公司合作，今天推出了 Smart Quant Neuro 3D。这项创新发展代表了在为多发性硬化症 (MS)、创伤性脑损伤 (TBI) 和痴呆症等神经系统疾病的诊断和治疗评估提供客观决策支援方面取得的重大进展。

目录

第 1 章：脑疾病模式与软体市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按产品类型分類的脑疾病模式与软体市场片段
    • 按患者类型分類的脑疾病模式和软体市场片段
    • 依适应症分類的脑疾病模式与软体市场片段
    • 最终用户的脑疾病模式与软体市场片段
    • 按国家/地区分類的脑疾病模式和软体市场片段
    • 按地区分類的脑疾病模式和软体市场片段
  • 竞争洞察

第 3 章：脑疾病模式与软体主要市场趋势

  • 脑疾病模式与软体市场驱动因素
    • 市场驱动因素的影响分析
  • 脑疾病模式与软体市场限制
    • 市场限制影响分析
  • 脑疾病治疗方式与软体市场机会
  • 脑疾病模式与软体市场未来趋势

第 4 章：脑疾病模式与软体产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：脑疾病模式与软体市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：脑疾病模式与软体市场格局

  • 2023 年脑部疾病模式与软体市场占有率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：脑疾病模式与软体市场 - 按产品类型

  • 概述
    • 按产品类型分類的细分市场占有率分析
    • 大脑分析软体
    • 脑部影像方式
      • CT设备
      • 核磁共振设备
      • PET设备
      • 正子电脑断层扫描
      • PET-MRI

第 8 章：脑疾病模式与软体市场 - 依病患类型

  • 概述
    • 按患者类型分類的细分市场份额分析
    • 成年人
    • 婴儿
    • 儿科

第 9 章：脑疾病模式与软体市场 - 按适应症

  • 概述
    • 按指标分類的细分市场占有率分析
    • 创伤性脑损伤 (TBI)
    • 头痛疾病
    • 癫痫
    • 睡眠障碍
    • 帕金森氏症
    • 中风
    • 亨丁顿舞蹈症
    • 失智

第 10 章：脑疾病模式与软体市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 医院和诊所
    • 门诊手术中心
    • 诊断影像中心

第 11 章：脑疾病模式与软体市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美脑部疾病治疗方式与软体主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按产品类型）
    • 北美市场规模和预测（按患者类型）
    • 北美市场规模和预测（按指标）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲脑疾病治疗方式与软体主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按产品类型）
    • 欧洲市场规模和预测（按患者类型）
    • 欧洲市场规模与预测（按指标）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区脑疾病治疗方式及软体主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（依产品类型）
    • 亚太地区市场规模和预测（按患者类型）
    • 亚太地区市场规模与预测（依指标）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲脑部疾病治疗方式与软体主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按产品类型）
    • 拉丁美洲市场规模与预测（按患者类型）
    • 拉丁美洲市场规模与预测（按指标）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲脑部疾病治疗方式和软体主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按产品类型）
    • 中东和非洲市场规模及预测（按患者类型）
    • 中东和非洲市场规模及预测（依指标）
    • 中东和非洲市场规模和预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 12 章：主要供应商分析 - 脑疾病模式与软体产业

  • 竞争仪表板
  • 公司简介
    • Quantib
    • Brainomix
    • Qure.ai
    • GE Company
    • Imaging Biometrics, LLC
    • United Imaging Healthcare Co. Ltd.
    • Siemens
    • Healthineers AG
    • KONINKLIJKE PHILIPS ELECTRONICS NV
    • Canon Inc.
    • VUNO Inc.
    • Aspect Imaging
    • IXICO
    • QMENTA
    • Cortechs.ai
    • AI Analysis, Inc.
    • FUJIFILM Holdings Corporation
    • Others

第 13 章：360 度分析师视角

第 14 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV3594

REPORT HIGHLIGHT

Brain Disease Modalities and Software Market size was valued at USD 13,690.32 Million in 2023, expanding at a CAGR of 5.90% from 2024 to 2032.

The diagnosis of brain diseases through the use of multiple imaging modalities has demonstrated enhanced effectiveness when compared to the application of a single modality. However, the availability of multi-modal data in clinical practice is often limited due to financial constraints or the associated risks of radiation exposure. The modalities and software utilized for brain disease encompass a diverse range of technologies and applications aimed at diagnosing, monitoring, and treating various neurological disorders. These tools are vital in contemporary neurology, offering extensive diagnostic capabilities, supporting research initiatives, and improving treatment and rehabilitation results for patients suffering from neurological conditions.

Brain Disease Modalities and Software Market- Market Dynamics

The increasing prevalence of neurological disorders and demands for safer and non-invasive imaging devices is expected to drive the growth of the market

With the aging of the global population, there is a notable rise in the prevalence of neurological disorders, including Alzheimer's disease, Parkinson's disease, multiple sclerosis, and epilepsy. This expanding demographic of patients necessitates the development of sophisticated diagnostic and therapeutic approaches. In 2021, neurological disorders accounted for 443 million years of healthy life lost due to illness, disability, and premature mortality (measured in disability-adjusted life years), positioning them as the leading cause of the global disease burden, surpassing cardiovascular diseases, as reported by the Institute for Health Metrics and Evaluation. Non-invasive imaging techniques, such as MRI and PET scans, present a safer alternative to invasive methods, minimizing the risk of complications and discomfort for patients, which in turn promotes their wider acceptance. Additionally, advancements in imaging technologies, including high-resolution MRI, functional MRI (fMRI), and enhanced PET scans, create opportunities for the Brain Disease Modalities and Software market. However, limited awareness and accessibility may pose challenges to the market's growth.

Brain Disease Modalities and Software Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.90% over the forecast period (2024-2032)

Based on product type segmentation, Brain Imaging Modalities was predicted to show maximum market share in the year 2023

Based on Patient Type segmentation, Pediatrics was the leading type in 2023

Based on Indication segmentation, Traumatic Brain Injury (TBI) was the leading type in 2023

Based on End-User segmentation, Diagnostic Imaging Centers were the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Brain Disease Modalities and Software Market- Segmentation Analysis:

The Global Brain Disease Modalities and Software Market is segmented based on Product Type, Patient Type, Indication, End-User, and Region.

The market is segmented into two categories according to product type: Brain Analysis Software and Brain Imaging Modalities. Brain Imaging Modalities holds the majority share in the market. Within this sector, brain imaging modalities are crucial in offering a comprehensive understanding of brain structure and function.

The market is segmented into three groups according to Patient Type: Adults, Infants, and Pediatrics. Pediatrics holds the largest share of the market. Specialized imaging modalities and software solutions are essential in pediatric neurology to effectively diagnose and treat brain diseases in young patients.

The market is segmented into eight categories according to Indication: Traumatic Brain Injury (TBI), Headache disorders, Epilepsy, Sleep disorders, Parkinson's disease, Stroke, Huntington's disease, and Dementia. Traumatic Brain Injury (TBI) holds the largest share in the market. TBI is a significant focus area where cutting-edge brain imaging technologies and software solutions are utilized to enhance diagnosis, monitoring, and rehabilitation.

The market is segmented into three distinct categories according to the End-User: Hospitals and Clinics, Ambulatory Surgery Centers, and Diagnostic Imaging Centers. Among these, Diagnostic Imaging Centers hold a dominant position in the market. These facilities employ various brain imaging techniques and software applications to diagnose, monitor, and manage neurological disorders.

Brain Disease Modalities and Software Market- Geographical Insights

This market is geographically extensive, encompassing North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These areas are further categorized based on the countries contributing to business activities. North America is the leading region, primarily due to the increasing integration of artificial intelligence in medical imaging and significant technological advancements. Specifically, the United States and Canada are at the forefront of incorporating AI and machine learning into medical imaging and diagnostic software. These innovations facilitate enhanced image analysis, boost diagnostic precision, and optimize workflows, thereby providing North American firms with a competitive advantage. In 2020, the American College of Radiology (ACR) was surveyed to assess the utilization of AI among its members in clinical settings, receiving 1,427 responses, which revealed that 33.5% of radiologists were employing AI in their practices. Europe ranks as the second-largest region for market growth, attributed to high healthcare expenditure and adoption rates.

Brain Disease Modalities and Software Market- Competitive Landscape:

The Brain Disease Modalities and Software Market exhibits a high level of competition, with a multitude of participants striving to secure market share through innovation, strategic alliances, and advancements in technology. Companies are making substantial investments in research and development to create state-of-the-art imaging modalities and software solutions. Significant emphasis is placed on artificial intelligence and machine learning, which are pivotal in improving diagnostic precision and operational efficiency. Leading firms are acquiring smaller enterprises and startups to broaden their technological capabilities and access novel innovations in the diagnosis and treatment of brain diseases. Additionally, organizations are enhancing their market presence by penetrating new geographic territories and emerging markets, thereby leveraging the increasing demand for sophisticated brain disease diagnostic tools.

Recent Developments:

On May 6, 2022, during the International Society for Magnetic Resonance in Medicine (ISMRM) 2022 Annual Meeting, GE Healthcare announced the further advancement of its innovative deep learning image reconstruction solution, AIR Recon DL, to its extensive customer base through both upgrades and new purchases across its MR product portfolio.

Royal Philips, a prominent global entity in health technology, in collaboration with Synthetic MR, a company specializing in magnetic resonance imaging (MRI) software solutions based in Linkoping, Sweden, has today unveiled Smart Quant Neuro 3D. This innovative development represents a significant progression in providing objective decision support for the diagnosis and therapeutic evaluation of neurological conditions such as multiple sclerosis (MS), traumatic brain injury (TBI), and dementia.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BRAIN DISEASE MODALITIES AND SOFTWARE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Quantib
  • Brainomix
  • Qure.ai
  • GE Company
  • Imaging Biometrics, LLC
  • United Imaging Healthcare Co. Ltd.
  • Siemens
  • Healthineers AG
  • KONINKLIJKE PHILIPS ELECTRONICS NV
  • Canon Inc.
  • VUNO Inc.
  • Aspect Imaging
  • IXICO
  • QMENTA
  • Cortechs.ai
  • A.I. Analysis, Inc.
  • FUJIFILM Holdings Corporation
  • Others

GLOBAL BRAIN DISEASE MODALITIES AND SOFTWARE MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Brain Analysis Software
  • Brain Imaging Modalities
  • CT Devices
  • MRI Devices
  • PET Devices
  • PET-CT
  • PET-MRI

GLOBAL BRAIN DISEASE MODALITIES AND SOFTWARE MARKET, BY PATIENT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Adults
  • Infants
  • Pediatrics

GLOBAL BRAIN DISEASE MODALITIES AND SOFTWARE MARKET, BY INDICATION- MARKET ANALYSIS, 2019 - 2032

  • Traumatic Brain Injury (TBI)
  • Headache disorders
  • Epilepsy
  • Sleep disorders
  • Parkinson's disease
  • Stroke
  • Huntington's disease
  • Dementia

GLOBAL BRAIN DISEASE MODALITIES AND SOFTWARE MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals and Clinics
  • Ambulatory Surgery Centers
  • Diagnostic Imaging Centers

GLOBAL BRAIN DISEASE MODALITIES AND SOFTWARE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Brain Disease Modalities and Software Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Brain Disease Modalities and Software Market Snippet by Product Type
    • 2.1.2. Brain Disease Modalities and Software Market Snippet by Patient Type
    • 2.1.3. Brain Disease Modalities and Software Market Snippet by Indication
    • 2.1.4. Brain Disease Modalities and Software Market Snippet by End-User
    • 2.1.5. Brain Disease Modalities and Software Market Snippet by Country
    • 2.1.6. Brain Disease Modalities and Software Market Snippet by Region
  • 2.2. Competitive Insights

3. Brain Disease Modalities and Software Key Market Trends

  • 3.1. Brain Disease Modalities and Software Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Brain Disease Modalities and Software Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Brain Disease Modalities and Software Market Opportunities
  • 3.4. Brain Disease Modalities and Software Market Future Trends

4. Brain Disease Modalities and Software Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Brain Disease Modalities and Software Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Brain Disease Modalities and Software Market Landscape

  • 6.1. Brain Disease Modalities and Software Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Brain Disease Modalities and Software Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. Brain Analysis Software
    • 7.1.3. Brain Imaging Modalities
      • 7.1.3.1. CT Devices
      • 7.1.3.2. MRI Devices
      • 7.1.3.3. PET Devices
      • 7.1.3.4. PET-CT
      • 7.1.3.5. PET-MRI

8. Brain Disease Modalities and Software Market - By Patient Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Patient Type, 2023 & 2032 (%)
    • 8.1.2. Adults
    • 8.1.3. Infants
    • 8.1.4. Paediatrics

9. Brain Disease Modalities and Software Market - By Indication

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Indication, 2023 & 2032 (%)
    • 9.1.2. Traumatic Brain Injury (TBI)
    • 9.1.3. Headache disorders
    • 9.1.4. Epilepsy
    • 9.1.5. Sleep disorders
    • 9.1.6. Parkinson's disease
    • 9.1.7. Stroke
    • 9.1.8. Huntington's disease
    • 9.1.9. Dementia

10. Brain Disease Modalities and Software Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2. Hospitals and Clinics
    • 10.1.3. Ambulatory Surgery Centers
    • 10.1.4. Diagnostic Imaging Centers

11. Brain Disease Modalities and Software Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Brain Disease Modalities and Software Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Brain Disease Modalities and Software Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Brain Disease Modalities and Software Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Brain Disease Modalities and Software Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Brain Disease Modalities and Software Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Brain Disease Modalities and Software Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Quantib
    • 12.2.2. Brainomix
    • 12.2.3. Qure.ai
    • 12.2.4. GE Company
    • 12.2.5. Imaging Biometrics, LLC
    • 12.2.6. United Imaging Healthcare Co. Ltd.
    • 12.2.7. Siemens
    • 12.2.8. Healthineers AG
    • 12.2.9. KONINKLIJKE PHILIPS ELECTRONICS NV
    • 12.2.10. Canon Inc.
    • 12.2.11. VUNO Inc.
    • 12.2.12. Aspect Imaging
    • 12.2.13. IXICO
    • 12.2.14. QMENTA
    • 12.2.15. Cortechs.ai
    • 12.2.16. A.I. Analysis, Inc.
    • 12.2.17. FUJIFILM Holdings Corporation
    • 12.2.18. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us